These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1760628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Endocrinal sequela in bone marrow transplantations during childhood and adolescence].
    Le Heup B, von Bueltzingloewen A, Bordigoni P, Sommelet D, Pierson M.
    Ann Pediatr (Paris); 1993 Sep; 40(7):463-8. PubMed ID: 8239398
    [Abstract] [Full Text] [Related]

  • 3. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
    Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT.
    Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
    [Abstract] [Full Text] [Related]

  • 4. Endocrine function after bone marrow transplantation for thalassemia.
    Galimberti M, De Sanctis V, Lucarelli G, Polchi P, Angelucci E, Baronciani D, Vullo C, Bagni B.
    Bone Marrow Transplant; 1991 May; 7 Suppl 2():74. PubMed ID: 1878729
    [No Abstract] [Full Text] [Related]

  • 5. Growth and development following marrow transplantation for leukemia.
    Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR.
    Blood; 1986 Nov; 68(5):1129-35. PubMed ID: 3533180
    [Abstract] [Full Text] [Related]

  • 6. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
    Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ.
    Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
    [Abstract] [Full Text] [Related]

  • 7. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation.
    Giorgiani G, Bozzola M, Cisternino M, Locatelli F, Gambarana D, Bonetti F, Zecca M, Lorini R, Severi F.
    Bone Marrow Transplant; 1991 Sep; 8 Suppl 1():53. PubMed ID: 1760641
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth failure in children after total body irradiation preparative for bone marrow transplantation.
    Hovi L, Saarinen UM, Siimes MA.
    Bone Marrow Transplant; 1991 Sep; 8 Suppl 1():10-3. PubMed ID: 1760625
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of allogeneic bone marrow transplantation on the endocrine system in children.
    Dopfer R, Ranke MB, Einsele H, Ehninger G, Blum WF, Niethammer D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Sep; 116(3-4):541-5. PubMed ID: 2480305
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
    Kanfer EJ, Buckner CD, Fefer A, Storb R, Appelbaum FR, Hill RS, Amos D, Doney KC, Clift RA, Shulman HM.
    Bone Marrow Transplant; 1987 Apr; 1(4):339-46. PubMed ID: 3332142
    [Abstract] [Full Text] [Related]

  • 18. Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
    Petersen FB, Buckner CD, Appelbaum FR, Clift RA, Sanders JE, Bensinger WI, Storb R, Witherspoon RP, Sullivan KM, Bearman SI.
    Bone Marrow Transplant; 1989 Nov; 4(6):617-23. PubMed ID: 2684307
    [Abstract] [Full Text] [Related]

  • 19. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
    Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF.
    Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
    Lynch MH, Petersen FB, Appelbaum FR, Bensinger WI, Clift RA, Storb R, Sanders JE, Hansen JA, Buckner CD.
    Bone Marrow Transplant; 1995 Jan; 15(1):59-64. PubMed ID: 7742756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.